Literature DB >> 32665153

Response to Letter to the Editor Titled "Risk Modeling for Unplanned Intensive Care Unit (ICU) Admission".

Kamolsak Sukhonthamarn1, Matthew J Grosso2, Javad Parvizi2.   

Abstract

Entities:  

Year:  2020        PMID: 32665153      PMCID: PMC7205677          DOI: 10.1016/j.arth.2020.05.005

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


× No keyword cloud information.
To the Editor in reply We are grateful to the letter authors for their interest in our study regarding risk factors for unplanned intensive care unit (ICU) admission after elective total joint arthroplasty (TJA), which was recently published in the Journal of Arthroplasty [1]. We agreed with the authors that in this arduous situation of the COVID-19 pandemic nationwide and around the world, issues related to medical resource utilization have become paramount for health care providers. Therefore, the American College of Surgeons and the Centers for Medicare and Medicaid Services have recommended postponing or canceling elective procedures, including TJA [2,3]. The questions from the letter writers are timely and appropriate regarding triage of urgent procedures related to TJA, including periprosthetic joint infection, periprosthetic fracture, and prosthetic dislocation. Our ultimate goal is to have an arthroplasty procedure based calculator that can cover these urgent procedures, similar to the current American College of Surgeons NSQIP risk calculator [4]. As we hopefully return to normalization during this critical period and restart elective cases, we hope our findings in the published study can help surgeons reduce the risk of ICU admission. We report significantly increased risks with bilateral versus unilateral hip [OR 13.2 (95% confidence interval, 4.9-31.4)] and knee arthroplasty [OR 10.8 (5.8-19.9)]. Moreover, we demonstrated cutoff values for age, BMI, estimated blood loss, and surgical duration, which are clinically relevant factors for ICU admission for both hip and knee arthroplasty, which may help orthopedics surgeons for preoperative decision-making and management. There is previously published work on predictors and risk-stratified model development, which was created from stratified preoperative and intraoperative factors to predict unplanned ICU admission after total hip arthroplasty [[5], [6], [7]]. We think this model is interesting and important for clinical use. Therefore, as suggested by the letter writers, we are developing a risk calculator tool from our database and extending it to evaluate multiple preoperative factors that influence and weight the risk for ICU admission. We want to thank the authors for their invaluable comments and suggestions. We hope that our future work can further help plan appropriately for health care resource management, especially in this time of crisis for both surgeons and patients.
  4 in total

1.  Prospective study of unplanned admission to the intensive care unit after total hip arthroplasty.

Authors:  Atul F Kamath; Jacob T Gutsche; Zev N Kornfield; Keith D Baldwin; Laura M Kosseim; Craig L Israelite
Journal:  J Arthroplasty       Date:  2013-03-16       Impact factor: 4.757

2.  Unplanned admission to the intensive care unit after total hip arthroplasty.

Authors:  Atul F Kamath; Caitlin L McAuliffe; Keith D Baldwin; Jared B Lucas; Laura M Kosseim; Craig L Israelite
Journal:  J Arthroplasty       Date:  2012-03-06       Impact factor: 4.757

3.  Risk Factors for Unplanned Admission to the Intensive Care Unit After Elective Total Joint Arthroplasty.

Authors:  Kamolsak Sukhonthamarn; Matthew J Grosso; Matthew B Sherman; Camilo Restrepo; Javad Parvizi
Journal:  J Arthroplasty       Date:  2020-03-06       Impact factor: 4.757

4.  Which patients need critical care intervention after total joint arthroplasty? : a prospective study of factors associated with the need for intensive care following surgery.

Authors:  P M Courtney; C M Melnic; J Gutsche; E L Hume; G-C Lee
Journal:  Bone Joint J       Date:  2015-11       Impact factor: 5.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.